In summary, our study elucidates the pivotal role of the PRRX1-OLR1 regulatory axis as a key determinant in the promotion of cancer-associated fibroblast (CAF)-mediated lung cancer progression and immune evasion. The gene discussed is PRRX1; the disease is lung cancer.